Sitemap

December 12, 2012 Articles

Filter by Available Specialty
  1. aap Implantate AG gets 510(k) clearance for trauma plating system
  2. Acute ametropia linked to attention deficit hyperactivity disorder
  3. Adverse events increased among children treated with TMP-SMX for SSTI
  4. Adverse events increased among children treated with TMP-SMX for SSTI
  5. Bedroom TV viewing increased obesity, cardiometabolic risk in children
  6. CBT reduced depression in patients unresponsive to antidepressants
  7. Chest compression-only CPR improved survival for out-of-hospital sudden cardiac arrest
  8. Excellent long-term survival found for femoral component revisions
  9. FDA approves supplemental new drug application for Rescula
  10. FDA updates safety review on CV concerns with Chantix
  11. Genome sequencing identified HER-2 mutations as therapy targets
  12. Healio Minute Wednesday, Dec. 12, 2012 Edition: Smoking and death, aspirin improves cancer survival, norovirus in restaurants
  13. IDSA urges USPSTF to reconsider HCV testing recommendation
  14. Infants born prematurely, small showed greater risk for esophagitis
  15. Intravitreal recombinant tissue plasminogen activator, gas injection improve treatment of submacular hemorrhage
  16. Loosening, rotator cuff deficiency common with cemented total shoulder replacement
  17. Measles, polio immunization campaign targets children in Syria
  18. Nonrefractive visual impairment on the rise in US adults
  19. Pelvic morphology helps diagnose development dysplasia of the hip
  20. Protease inhibitors improved sustained virologic response rate in HCV
  21. Researchers develop testing system for endocrine disrupting chemicals
  22. Study of dabigatran in artificial heart valve patients halted
  23. Systemic endothelial dysfunction common, cardiovascular risk high in cirrhotic patients
  24. Tocilizumab/methotrexate efficacy superior to other combined therapies for RA patients
  25. Transcatheter valve may be effective for failed bioprosthetic pulmonary valves
  26. Two years of adjuvant trastuzumab yielded no extra benefit
  27. Veterans report stump dermatoses almost 40 years after amputation